These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8956704)

  • 1. NHS breast screening programme: is the high incidence of interval cancers inevitable?
    Asbury D; Boggis CR; Sheals D; Threlfall AG; Woodman CB
    BMJ; 1996 Nov; 313(7069):1369-70. PubMed ID: 8956704
    [No Abstract]   [Full Text] [Related]  

  • 2. Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers.
    Welch HG; Schwartz LM; Woloshin S
    BMJ; 2006 Mar; 332(7543):727. PubMed ID: 16565136
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality assurance in Trent Regional Health Authority's breast screening programme.
    Thornhill P
    Radiogr Today; 1990 Apr; 56(635):11-3. PubMed ID: 2363814
    [No Abstract]   [Full Text] [Related]  

  • 4. Planning for quality in the NHS breast screening programme.
    Gray JA
    Qual Health Care; 1992 Jun; 1(2):119-23. PubMed ID: 10136841
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of double reading mammograms in breast screening.
    Husien AM
    Clin Radiol; 1995 Jan; 50(1):67. PubMed ID: 7834982
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of double reading mammograms in breast screening.
    McLean L; Simpson W
    Clin Radiol; 1995 Jan; 50(1):67. PubMed ID: 7834983
    [No Abstract]   [Full Text] [Related]  

  • 7. Global summit on mammographic screening.
    Boyle P
    Ann Oncol; 2003 Aug; 14(8):1159-60. PubMed ID: 12881366
    [No Abstract]   [Full Text] [Related]  

  • 8. Should women 40 to 49 years of age be offered mammographic screening?
    Trop I; Deck W
    Can Fam Physician; 2006 Sep; 52(9):1050-2. PubMed ID: 17279208
    [No Abstract]   [Full Text] [Related]  

  • 9. The National Breast Screening Programme: the first 5,000 women screened in Northern Ireland.
    O'Doherty AJ; Crothers JG; Majury CW
    Ulster Med J; 1991 Oct; 60(2):150-3. PubMed ID: 1785147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.
    Woodman CB; Threlfall AG; Boggis CR; Prior P
    BMJ; 1995 Jan; 310(6974):224-6. PubMed ID: 7866124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Short-interval follow-up mammography: are we doing the right thing?
    Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
    J Natl Cancer Inst; 2003 Aug; 95(15):1175-6. PubMed ID: 12902453
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost of extending the NHS breast screening age range in England.
    Bewley S; Blennerhassett M; Payne M
    BMJ; 2019 Apr; 365():l1293. PubMed ID: 30971394
    [No Abstract]   [Full Text] [Related]  

  • 13. Swedish study questions mammography screening programmes.
    Mayor S
    BMJ; 1999 Mar; 318(7184):621. PubMed ID: 10066185
    [No Abstract]   [Full Text] [Related]  

  • 14. Mammography and breast cancer.
    Pomare EW; Dady P; Marshall B; Glasgow HM
    N Z Med J; 1990 Apr; 103(888):192. PubMed ID: 2330173
    [No Abstract]   [Full Text] [Related]  

  • 15. The risks and benefits of screening mammography.
    Health Technol; 1987; 1(1):19-25. PubMed ID: 10295360
    [No Abstract]   [Full Text] [Related]  

  • 16. Other voices weigh in on mammography decision.
    Marwick C
    JAMA; 1997 Apr; 277(13):1027-8. PubMed ID: 9091679
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical audit and standard setting for symptomatic breast imaging in South Thames region.
    Mills P; Foord K; Trevethick P
    Clin Radiol; 1997 Jan; 52(1):55-8. PubMed ID: 9022582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast screening: process and outcome.
    Rogers C
    Clin Oncol (R Coll Radiol); 1999; 11(1):4-5. PubMed ID: 10194580
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
    Vreemann S; Gubern-Mérida A; Schlooz-Vries MS; Bult P; van Gils CH; Hoogerbrugge N; Karssemeijer N; Mann RM
    Radiology; 2018 Feb; 286(2):443-451. PubMed ID: 29040037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography: reviewing the evidence. Epidemiology aspect.
    Miller AB
    Can Fam Physician; 1993 Jan; 39():85-90. PubMed ID: 8435565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.